A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
Public ClinicalTrials.gov record NCT06211764. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
17000139BLC3004: 17000139BLC3004 [SunRISe-5] Ph III HR NMIBC BCG Exp/UR Pap (N=250)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare disease free survival (DFS) in participants with recurrence of papillary-only high-risk non-muscle-invasive bladder cancer (HR-NMIBC) within 1 year of last dose of Bacillus Calmette-Guérin (BCG) therapy and who refused or are unfit for Radical Cystectomy (RC), receiving TAR-200 versus investigator's choice of single agent intravesical chemotherapy.
Study identification
- NCT ID
- NCT06211764
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 272 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 9, 2024 (Actual)
- Primary completion
- Nov 27, 2030 (Estimated)
- Completion
- Apr 14, 2031 (Estimated)
- Last update posted
- Sep 25, 2026
2024 – 2031
United States locations
- U.S. sites
- 29
- U.S. states
- 16
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Urology | Little Rock | Arkansas | 72211 | — |
| Genesis Research LLC 1 | Los Alamitos | California | 90720 | — |
| USC Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| University of California Irvine Medical Center | Orange | California | 92868 | — |
| University of California San Francisco | San Francisco | California | 94158 2549 | — |
| Genesis Research LLC | Torrance | California | 90503 | — |
| Colorado Clinical Research | Lakewood | Colorado | 80228 | — |
| Florida Urology Partners | Riverview | Florida | 33578 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| UroPartners | Chicago Ridge | Illinois | 60415 | — |
| Urology of Indiana | Carmel | Indiana | 46032 | — |
| First Urology, PSC | Jeffersonville | Indiana | 47130 | — |
| Wichita Urology Group | Wichita | Kansas | 67226 | — |
| Comprehensive Urology | Royal Oak | Michigan | 48073 | — |
| Specialty Clinical Research of St Louis | St Louis | Missouri | 63141 | — |
| Associated Medical Professionals | Syracuse | New York | 13210 | — |
| The Urology Group | Cincinnati | Ohio | 45212 | — |
| Central Ohio Urology Group | Gahanna | Ohio | 43230 | — |
| Centers for Advanced Urology LLC d b a MidLantic Urology | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Ralph H. Johnson Veterans Affairs Medical Center | Charleston | South Carolina | 29401 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Low Country Urology Clinics | North Charleston | South Carolina | 29406 | — |
| Urology Associates | Nashville | Tennessee | 37209 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Urology Austin | Austin | Texas | 78759 | — |
| Urology Clinics of North Texas | Dallas | Texas | 75231 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Houston Metro Urology | Houston | Texas | 77027 | — |
| Spokane Urology | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06211764, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06211764 live on ClinicalTrials.gov.